Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1985 | 12-1984 | 12-1983 | 12-1982 | 12-1981 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,009 | 34 | 90 | 486 | N/A |
| Marketable Securities | 500 | 1 | 1,505 | 277 | N/A |
| Other current assets | 83 | 8 | 73 | 51 | 0 |
| TOTAL | $2,592 | $43 | $1,668 | $814 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 126 | 101 | 73 | 19 | N/A |
| Investments And Advances | 0 | 0 | 1 | 1 | 0 |
| Other Non-Current Assets | 4 | 0 | 18 | 4 | 0 |
| TOTAL | $130 | $101 | $93 | $24 | $N/A |
| Total Assets | $2,722 | $144 | $1,761 | $838 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 662 | 213 | 127 | 98 | 0 |
| Other current liabilities | 46 | 173 | 99 | 0 | N/A |
| TOTAL | $1,310 | $409 | $225 | $598 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $91 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,401 | $535 | $225 | $598 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 84 | 75 | 75 | 70 | N/A |
| Retained earnings | -12,034 | -8,723 | 0 | -3,487 | N/A |
| Other shareholders' equity | 0 | 0 | -6,621 | 0 | 0 |
| TOTAL | $1,321 | $-391 | $1,535 | $240 | $N/A |
| Total Liabilities And Equity | $2,722 | $144 | $1,761 | $838 | $0 |